Work

Preclinical toxicity of a geldanamycin analog, 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin (17-DMAG), in rats and dogs: potential clinical relevance

Year: 2005

Type: article

Source: Cancer Chemotherapy and Pharmacology

DOI: 10.1007/s00280-005-1000-9

Authors: Elizabeth R. Glaze, Amy L. Lambert, Adaline C. Smith, John G. Page, William D. Johnson, David L. McCormick, Alan P. Brown, Barry S. Levine, Joseph M. Covey, Merrill J. Egorin, Julie L. Eiseman, Julianne L. Holleran, Edward A. Sausville, Joseph E. Tomaszewski

Institutions: National Cancer Institute, Southern Research Institute, IIT Research Institute, Illinois Institute of Technology, University of Illinois Chicago, University of Pittsburgh, UPMC Hillman Cancer Center

Language: English

Topic: Heat shock proteins research

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, National Cancer Institute

Awards: PRECLINICAL TOXICOLOGY &PHARMACOLOGY OF DRUGS DEVELOPED, PRECLINICAL TOXICOLOGY &PHARMACOLOGY OF DRUGS DEVELOPED, PRECLINICAL TOXICOLOGY &PHARMACOLOGY OF DRUGS DEVELOPED, G2624524742, PRECLINICAL PHARMACOLOGICAL STUDIES OF ANTITUMOR AND ANT, G424558205, G7072519283, G8160483195, Cancer Center Support Grant, G930925229

OpenAlex ID: W2076681068

FWCI: 3.339

Cites: 20

Cited by: 115

Related to: 10